Fresenius has issued a software release to address issues that could interrupt treatment with its Ivenix large volume pumps.
The U.S. Food and Drug Administration has issued warning letters to 30 telehealth companies for making false or misleading claims about compounded versions of popular GLP-1 weight‑loss drugs, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results